GenCanna’s latest white label purchase deepens penetration of UK and Europe

GenCanna continues to bet on the future of UK bulk and white label CBD products with the purchase of another company specialising in those areas.

The Kentucky company has continued its return from bankruptcy by acquiring CBD Capital, a provider of CBD distillate, isolate and water-soluble bulk ingredients as well as white and private label services to the UK, the EU and markets worldwide.

It follows the earlier acquisition of UK-based Taylor Mammon, another major player in the same field.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ GenCanna’s latest white label purchase deepens penetration of UK and Europe ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ GenCanna’s latest white label purchase deepens penetration of UK and Europe ”






      GenCanna continues to bet on the future of UK bulk and white label CBD products with the purchase of another company specialising in those areas.

      The Kentucky company has continued its return from bankruptcy by acquiring CBD Capital, a provider of CBD distillate, isolate and water-soluble bulk ingredients as well as white and private label services to the UK, the EU and markets worldwide.

      It follows the earlier acquisition of UK-based Taylor Mammon, another major player in the same field.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik